Background: Exposure to allergens, such as house dust mite (HDM), through the skin often precedes allergic inflammation in the lung. It was proposed that T H 2 sensitization through the skin occurs when skin barrier function is disrupted by, for example, genetic predisposition, mechanical damage, or the enzymatic activity of allergens. Objective: We sought to study how HDM applied to unmanipulated skin leads to T H 2 sensitization and to study which antigen-presenting cells mediate this process. Methods: HDM was applied epicutaneously by painting HDM on unmanipulated ear skin or under an occlusive tape. HDM challenge was through the nose. Mouse strains lacking different dendritic cell (DC) populations were used, and 1-DER T cells carrying a transgenic T-cell receptor reactive to Der p 1 allergen were used as a readout for antigen presentation. The T H 2-inducing capacity of sorted skin-derived DC subsets was determined by means of adoptive transfer to naive mice. Results: Epicutaneous HDM application led to T H 2 sensitization and eosinophilic airway inflammation upon intranasal HDM challenge. Skin sensitization did not require prior skin damage or enzymatic activity within HDM extract, yet was facilitated by applying the allergen under an occlusive tape. Primary proliferation of 1-DER T cells occurred only in the regional skin-draining lymph nodes. Epicutaneous sensitization was found to be driven by 2 variants of interferon regulatory factor
Although most clinically relevant allergens, such as house dust mite (HDM) fecal pellets, pollen, animal dander, and fungal spores, are easily inhaled aeroallergens, the precise route by which patients mount an adaptive immune response to them has been poorly defined. It is well known that airborne particles can trigger an immune response in the respiratory epithelium that leads to systemic sensitization. [1] [2] [3] However, it is equally possible that aeroallergens enter the body through other routes. Because the dust mite Dermatophagoides pteronyssinus feeds on human skin, HDM allergens are abundant in mattress covers and blankets and could be recognized by the structural and immune cells of the skin barrier. 4, 5 The idea that sensitization can occur through the skin is also supported by the fact that children who later have allergic asthma or rhinitis often had eczema in the first year of life. 6 It has been hypothesized that some children might have an intrinsically altered skin barrier integrity, which could lead to increased penetration of allergens to the cells of the immune system. These children indeed show single nucleotide polymorphisms (SNPs) in genes encoding for skin barrier proteins, such as filaggrin. [7] [8] [9] However, these SNPs are only present in 20% of asthmatic patients, [10] [11] [12] suggesting that other mechanisms might be responsible for T H 2 sensitization through the skin. Intrinsic barrier defects in the skin are not a prerequisite for allergy development through that route. Many allergens, including the HDM allergens Der p 1 and Der p 9, are proteolytic enzymes that have the capacity to cleave tight junctions, which are abundantly present in skin and mucosal barriers and thus get access to immune cells across intact skin. Other risk allele SNPs associated with allergy and asthma are found in genes encoding regulators of the process of antigen presentation (eg, certain MHC haplotypes), pattern recognition receptors, and multiple cytokine (receptor) genes involved in the innate and adaptive immune system. Indeed, allergic sensitization occurs when allergens are recognized by pattern recognition receptors on antigen-presenting dendritic cells (DCs) that degrade the antigen into small peptides for presentation on MHC molecules to the T-cell receptor (TCR). 1, 2, 13 In the lungs and nose it has been shown that subsets of conventional dendritic cells (cDCs), especially those expressing the integrin CD11b and signal-regulatory protein alpha (SIRPa), and now referred to as type 2 conventional dendritic cells (cDC2s), are crucial for the recognition of aeroallergens and for subsequent development of T H 2 immunity to allergens, such as HDM, and development of asthma or allergic rhinitis. 1, 2, [14] [15] [16] [17] [18] [19] [20] [21] [22] Other DC subsets of the lung (type 1 cDCs [cDC1s] expressing X-C motif chemokine receptor 1 [XCR1] and the integrin CD103 or plasmacytoid DCs) induce tolerance to inhaled allergens. [23] [24] [25] If the skin is a portal for allergic sensitization through an intact skin barrier, then DCs are likely to play an equally important role. Also in the skin, different subsets of DCs with different anatomic localizations and functions have been described. [26] [27] [28] [29] Langerhans cells (LCs; expressing CD11c, Langerin [also known as CD207], and CD11b) are located in the epidermis and were long considered as the main antigen-presenting cells in the skin. In the dermis, studies have reported the presence of several cDC populations, such as cDC1s and cDC2s, which rely on the transcription factors interferon regulatory factor (IRF) 8 and IRF4, respectively, for their development and function. 22, [30] [31] [32] [33] During inflammation, monocyte-derived DCs (expressing CD11b and intermediate levels of the macrophage markers CD64 and MER proto-oncogene, tyrosine kinase [MERTK]) also get recruited to the skin. 32 IRF4-dependent cDC2s were recently reported to control T H 2 responses in the skin, [34] [35] [36] and this property was mostly restricted to Klf4-dependent CD11b 2 CD24 2 double-negative (DN) cDC2s. 36 However, in most studies using sensitization through the skin, pro-T H 2 antigens (papain, alum, and ovalbumin) have been injected through the skin or applied to the skin after tape stripping, causing either a direct breach of skin barrier integrity or irritation of the barrier through the process of tape stripping, 34, 35, 37 and no study has studied the role of DC subsets in the process of epicutaneous allergic sensitization.
In this article we address whether T H 2 immunity would occur in response to an aqueous extract of the ubiquitous environmental allergen HDM when applied epicutaneously on intact mouse ear skin. We demonstrate clear signs of systemic T H 2 sensitization that lead to allergic airway inflammation after airway allergen challenge. We found that HDM sensitization through this route did not require skin barrier disruption by tape stripping or the proteolytic activity of HDM, yet this sensitization was facilitated by applying the allergen under an occlusive tape that caused mild barrier impairment. Epicutaneous sensitization was mediated by 2 subsets of IRF4-expressing dermal cDC2s, whereas LCs were not required. These findings identify skin cDC2s as crucial players in T H 2 sensitization to common inhaled allergens that enter the body through intact skin and can provoke features of allergic asthma.
METHODS Mice
C57Bl/6 mice were obtained from Harlan (Indianapolis, Ind) or generated in house and maintained in the animal facility of the Inflammation Research Center of Ghent under specific pathogen-free conditions. Langerin-diphtheria toxin receptor (DTR) transgenic mice were obtained from Dr Bernard Malissen (Centre d'Immunologie de Marseille-Luminy, Marseille, France).
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fl/fl mice were obtained from Dr William Agace (University of Lund, Lund, Sweden). 39 1-DER TCR transgenic mice in which CD4 T cells react to an immunodominant epitope in Der p 1 have been described in detail. 40 Experiments were approved by the animal ethical committees of the University of Ghent and the Inflammation Research Center.
Flow cytometry
To determine the cellular composition of bronchoalveolar lavage (BAL) fluids, cells were stained with mAbs directed against MHC class II (M5/ 114.15.2), CD11c (N418), CD19 (1D3), CD3 (145-2C11; all from eBioscience, San Diego, Calif), Siglec-F (E50-2440), and Ly-6G (1A8; BD, Biosciences, San Jose, Calif). For detection and phenotyping of DC subsets in cell suspensions of skin or skin-draining lymph nodes (LNs), cells were stained with MHC class II (M5/114; BioLegend, San Diego, Calif), CD11c (N418), CD103 (2E7), CD3 (145-2C11), CD19 (1D3), F4/80 (BM8), CD172a (P84; eBioscience), XCR1 (ZET; BioLegend), CD11b (M1/70), CD24 (M1/ 69), CD64 (X54-5/7.1), CD26 (H194-112), and SAV (BD Biosciences). For intracellular IRF4, IRF8, or CD207 staining, cells were fixed with a fixation/ permeabilization kit (eBioscience) before they were stained with labeled CD207 (929F3.01; Dendritics, Lyon, France), IRF8 (C19; eBioscience), or both or unlabeled IRF4 (M17; Santa Cruz Biotechnology, Dallas, Tex). Then unlabeled IRF4 was bound to labeled donkey anti-goat antibody (Invitrogen, Carlsbad, Calif). To check the purity and proliferation of CD4 1 1-DER T cells, the following antibodies were used: CD4 (RM4-5), CD3 (17A2), CD44 (IM7; eBioscience), CD45.1 (A20), CD45.2 (104), TCR Vb4 (KT4), and CD69 (H1,2F3; BD Biosciences). Dead cells were always excluded from the analysis by using the fixable viability dyes eFluor506 or eFluor780 (eBioscience). Acquisition of multicolor samples was done on an LSR Fortessa flow cytometer (BD Biosciences). Final analysis and graphic output were performed with FlowJo software (Tree Star, Ashland, Ore).
HDM labeling and uptake by DC subsets
HDM extract (Greer Laboratories, Lenoir, NC; Der p 1 content: 227.64 mg per vial; endotoxin content: 1397 EU per vial; protein content: 5.59 mg per vial) was labeled with AF647 succinimidyl ester (Life Technologies, Grand Island, NY) by the protein service facility at the Inflammation Research Center of Ghent. HDM (100 mg) was applied on ear skin, and analysis of uptake was performed in the skin or superficial cervical lymph nodes (SCLNs) by using flow cytometry at different time points.
Epicutaneous sensitization and development of allergic airway inflammation Sensitization was induced on day 0 by applying 100 mg of HDM in 20 mL of PBS (Dermatophagoides pteronyssinus extracts; Greer Laboratories) on the dorsal ear skin or shaved flank, which was then covered with a 5 mm 3 5 mm gauze under an acrylic adhesive waterproof film (Leukoflex; BSN Medical, Hamburg, Germany). The tape was gently removed with scissors, taking care to avoid skin stripping or abrasion. Mice were challenged intranasally with 10 mg of HDM on days 7 to 11 to induce allergic airway inflammation. On day 14, serum, BAL fluid and mediastinal LNs were collected and analyzed.
In experiments in which Langerin-DTR (Lang-DTR) mice were used, the animals were injected intraperitoneally with 500 ng of diphtheria toxin on the day before HDM epicutaneous sensitization.
Collection of sera, BAL fluid, and mediastinal LN cells
Blood was collected from the iliac vein for serum preparation. BAL fluid was obtained by injecting 3 3 1 mL of PBS containing EDTA into the cannulated trachea. MLN cells (2 3 10 6 cells/mL) were restimulated for 3 days ex vivo with 15 mg/mL HDM extracts in 96 round-bottom plates. Cytokine production was determined in supernatants by using specific ELISA (eBioscience).
Immunofluorescence staining of lung tissue sections
Seven-micrometer-thick lung slices were incubated with rat anti-Siglec-F (BD Biosciences) or mouse anti-Muc5ac antibodies (Abcam, Cambridge, United Kingdom). For Muc5ac staining, slides were treated with the Mouse on Mouse Staining Kit (Vector Laboratories, Burlingame, Calif), according to the manufacturer's instructions. Slides were then incubated with Cy3-labeled secondary antibodies, and nuclei were counterstained with 49-6-diamidino-2-phenylindole dihydrochloride before analysis on an LSM710 microscope (Zeiss, Oberkochen, Germany) equipped with a tunable 2-photon Mai Tai and a 561-nm laser. Analysis of the acquired images was done with Imaris software (Bitplane, Concord, Mass).
LNs and skin preparations for DC sorting
LNs were manually cut in small pieces, and these were enzymatically digested with 20 mg/mL Liberase research grade and 10 U of DNase (both from Roche, Mannheim, Germany) in RPMI medium for 30 minutes at 378C. Skin samples were incubated overnight at 48C with 200 mg/mL Dispase II (from Bacillus polymerase grade 2; Roche) to facilitate manual cutting and isolation of cells. Small skin pieces were further digested with 1.5 mg/mL Collagenase Type 4 (Worthington Biochemical, Lakewood, NJ) and 10 U of DNase (Roche) in RPMI medium buffered with HEPES and supplemented with 2% FCS. The suspension was resuspended for 30 minutes and provided with fresh digestion buffer for a total of 90 minutes at 378C. After digestion, debris and dead cells were removed with a density gradient (Percoll).
Carboxyfluorescein succinimidyl ester labeling of HDM-specific T cells
LNs and spleens from CD45.1 congenic 1-DER mice were isolated and homogenized in PBS through a 70-mm cell strainer (Falcon, a Corning Brand, NY). After red blood cell lysis, CD4
1 T cells were purified with the MagniSort Mouse CD4 T Cell Enrichment Kit (eBioscience), according to the manufacturer's protocol. Cell purity assessed by using flow cytometry and was greater than 98%. Isolated CD4 1 T cells were incubated for 7 minutes at 378C with 5 mmol/L CellTrace CFSE (Carboxyfluorescein succinimidyl ester; Thermo Fisher Scientific, Waltham, Mass) in FCS-free medium. Cells were washed with RPMI containing 10% FCS.
In coculture experiments 1-DER T cells were placed with sorted DC subsets for 3 days at a ratio of 5:1.
DC and 1-DER T-cell adoptive transfer
In experiments in which DCs were transferred, naive C57Bl/6 mice underwent epicutaneous application of PBS or HDM. Thirty-six hours later, SCLNs were collected, and cell suspensions were prepared. Cells were stained for the presence of different DC subsets. After washing, the different DC subsets were sorted on an Aria III (BD Biosciences). Twenty thousand cells were injected intradermally into naive recipient mice on day 0. On days 7 to 11, mice were challenged intranasally with 10 mg of HDM. On day 14, BAL fluid and lung-draining MLNs were collected and analyzed for the presence of eosinophils and T H 2 cytokine production, respectively.
In 1-DER adoptive transfer experiments 3 million CD4 1 CFSE-labeled 1-DER T cells were injected into mice through the tail vein. T-cell proliferation was assessed 4 and 7 days later by using flow cytometry.
HDM-specific ELISA
Ninety-six-well plates were coated with 100 mg/mL HDM extracts overnight at 48C. After washing, serum was incubated on the plates for 3 hours. Biotin-coupled anti-IgE detection antibodies and avidin-horseradish peroxidase reagent were then added for 1 hour. TMB substrate was added after extensive washing, and chemiluminescence was determined by using spectrophotometry (absorbance at 450 nm).
Transepidermal water loss measurement
Mouse bellies were shaved in the morning, and occlusive tape (Leukoflex) was applied on the shaved area in the evening. As a control, some mice did not receive a tape. One group of shaved mice were tape stripped 10 times before transepidermal water loss (TEWL) measurement. One day later, TEWL was measured with a Tewameter TM300 (Courage 1 Khazaka Electronic, Koeln, Germany).
Statistics
For all experiments, the difference between 2 groups was calculated with the Mann-Whitney U test for unpaired data. Differences were considered significant at a P value of less than .05.
RESULTS
Epicutaneous sensitization to HDM does not require skin damage
In several models of epicutaneous sensitization, antigens are applied on the skin after disruption of the stratum corneum using different mechanical methods, such as tape stripping, 37, 41, 42 or after applying irritating depilatory creams. 43 To be able to study epicutaneous sensitization to the relevant HDM allergen while minimally altering the skin barrier, we applied HDM extract to the backside of a mouse ear with a sterile gauze under an occlusive flexible dressing tape (Leukoflex) devoid of latex extracts. We gently removed the tape after 16 hours, taking care not to disturb epithelial cell integrity by cutting away rather than stripping the tape off. For comparison, we also included a group in which we applied the allergen under a similar occlusive tape on shaved flank skin. All mice were then challenged with HDM intranasally 7 days later for 5 days, and the degree of airway eosinophilic inflammation was read out 3 days after the last challenge (see Fig 1, A, for experimental setup). After challenge, all mice sensitized epicutaneously with HDM on the ears (HDM/ HDM group) had airway eosinophilia (Fig 1, B) , had HDMspecific IgE in the serum (Fig 1, C) , and showed strong IL-5 and IL-13 production when MLN cells were restimulated ex vivo with HDM (Fig 1, D) compared with mice applied with PBS epicutaneously (PBS/HDM group). However, when HDM was applied on shaved flank skin, the severity of all features of allergic inflammation was significantly higher than in mice in which the allergen was applied on the ears (Fig 1, B-D) . We also characterized lung changes more carefully. There was increased peribronchial and perivascular infiltration of Siglec-F 1 eosinophils in the HDM/HDM group compared with the PBS/HDM group (Fig 1, E) . Moreover, mice in the HDM/ HDM group showed increased staining intensity for Muc5ac, a gel-forming protein present in mucus lining the airways, particularly when there is goblet cell metaplasia, compared with control PBS/ HDM mice (Fig 1, E) . These data indicate that allergens applied epicutaneously on the skin can induce systemic T H 2 sensitization to allergen and cause features of allergic airway inflammation on repeated exposure to the lung when the same allergen is subsequently inhaled.
Although we took great care in avoiding manual barrier disruption by cutting away rather than stripping off the occlusive tape after 16 hours, we still wanted to study the effect of the occlusive dressing in our model. A good measure of epidermal barrier function is measurement of TEWL. Unfortunately, because of the size of the probe, we could not measure this on mouse ear skin. Therefore we measured the effect of occlusive tape removal on shaved back skin. For comparison, we also performed tape stripping by manually stripping off adhesive tape 10 times before TEWL measurement. As shown in Fig 1, F , overnight application of occlusive tape, followed by our gentle removal procedure, modified skin barrier integrity, as reflected by increased TEWL compared with that seen in mice that did not have a tape applied. However, the degree of barrier defect induced was much smaller compared with that after the tape-stripping procedure commonly used in allergen skin application models. This increased TEWL induced by the occlusive tape was associated with a very mild inflammatory response in the skin, as assessed based on the recruitment of innate Ly-6G hi neutrophils and MHC class II hi CD11c 1 DCs to the draining nodes 24 hours after tape application (Fig 1, G) . Whether sensitization can still be achieved by means of application of allergens on intact and unmanipulated skin or whether it always requires some degree of inflammation in the skin is still debated. 44 To address the effect of the occlusive tape on the strength of T H 2 responses to HDM, we applied an occlusive tape on the ears overnight. As a control for the tape effect, some mice did not receive a tape application. The next day, the occlusive tape was removed. All mice were then anesthetized, and 100 mg of HDM extract or PBS as a control was applied for 1 hour by painting the HDM solution on ear skin. After intranasal HDM challenge, even mice sensitized epicutaneously to HDM in the absence of prior tape application (No tape-HDM 1 hour epicutaneous) had airway eosinophilia (Fig 1, H) . However, removal of the overnight tape just before HDM sensitization (Tape ON-HDM 1 hour epicutaneous) further increased the strength of the model, as reflected by the increased BAL fluid eosinophilia (Fig 1, H) . In fact, the group of mice in which the tape was removed before HDM (Tape ON-HDM 1 hour epicutaneous) showed similar intensity of inflammation as a group of mice in which the HDM was applied under the tape overnight (HDM under tape ON; Fig 1, H) . These data point to the fact that T H 2 sensitization to HDM can be achieved even through intact unmanipulated ear skin but that sensitization is further enhanced if an occlusive tape is used.
Epicutaneous sensitization to HDM does not require proteolytic activity of HDM
We next wanted to understand how T H 2 sensitization to HDM could be achieved through the skin barrier and investigated whether the disruption of tight junctions by proteolytically active allergens contained in our HDM extracts (eg, Der p 1) could be involved in this process. For this, mice were sensitized epicutaneously with either HDM or heat-inactivated HDM under an occlusive dressing tape on mouse ears and were challenged with HDM intranasally. We verified that heat inactivation of HDM for 45 minutes at 958C inactivated the proteolytic activity of HDM (data not shown). Epicutaneous sensitization with HDM or heat-inactivated HDM induced similar numbers of BAL fluid eosinophils and lymphocytes (Fig 1, I ) and levels of cytokine production by MLN cells restimulated ex vivo with HDM (Fig 1, J) , indicating that the proteolytic activity of HDM was not required to induce epicutaneous T H 2 sensitization. Similar data were obtained when we used the highly selective cysteine protease inhibitor E64 (Fig 1, I and J) , in which case HDM sensitization was also intact.
T-cell activation after epicutaneous sensitization occurs in skin-draining LNs
We next wanted to study where sensitization to HDM occurred when applied on the skin. For this, we made use of the recently generated 1-DER mice, which express an MHC class II-restricted TCR specific for a Der p 1 [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] peptide (peptide sequence SCWAFSGVAATES), a major allergen of HDM. To test the importance of single versus dual TCR reactivity, these mice were generated on a Rag 2/2 C57Bl/6 background and a C57Bl/ 6 background, respectively. Four days after epicutaneous HDM application, proliferation of wild-type (WT) CD4 1 1-DER T cells only occurred in the SCLNs that drain the ear skin on the side of allergen application (Fig 2, A-C) . No primary T-cell divisions were detectable in the contralateral SCLNs or in other nondraining LNs, such as the inguinal LNs (Fig 2, B and C) or spleen (Fig 2, A) . A low percentage of divided 1-DER T cells could be recovered from the spleen, but these had a CFSEloCD44hi phenotype, suggesting they were recirculating T cells (Fig 2, A) . When Rag 2/2 1-DER T cells were injected into mice exposed to HDM epicutaneously, these cells showed higher proliferation and activation capacities in the draining SCLNs 4 days after HDM application (Fig 2, E and F) than WT 1-DER T cells (Fig 2, B and C) . The number of Rag 2/2 CFSE lo CD44 hi recirculating T cells was significantly increased in the inguinal LNs of mice exposed to HDM compared with those in animals undergoing PBS application (Fig 2, F) . Four and 7 days after epicutaneous HDM application, ear-draining SCLN cells were obtained from mice that had received WT 1-DER T cells and were restimulated with HDM for 3 days ex vivo (Fig 2, D) . The supernatants contained high amounts of IFN-g, IL-10, and IL-13 cytokines when cells were derived from mice injected with WT 1-DER T cells and exposed to HDM epicutaneously for 4 days (Fig 2, D) . In mice exposed to HDM for 7 days, IL-17 and IL-13 production was very high compared with that in mice exposed to PBS (Fig 2, D) . Similar cytokine profiles were observed in SCLN cells of mice injected with Rag 2/2 1-DER T cells (Fig 2, G) .
These data show that epicutaneous HDM application induces primary T-cell divisions only in SCLNs draining the ear to which the allergen was applied, subsequently leading to T H 2 and T H 17 cytokine production, as well as mild IFN-g induction. Similar responses were observed with WT 1-DER T cells bearing dual-TCR reactivity and Rag 2/2 1-DER cells bearing single-TCR reactivity and lacking naturally occurring regulatory T cells, indicating that the response induced by application of HDM extracts is specific for Der p 1. The proliferative response of 1-DER T cells observed after epicutaneous HDM application in WT mice was absent when the allergen was applied on the ears of Ccr7 DCs capture epicutaneous HDM in the skin and transport it to the draining LNs Priming of naive T cells is a function performed by DCs after they have captured antigens in the periphery and migrated to the nodes in a CCR7-dependent manner. The skin and skindraining LNs contain 5 major DC subsets, 22, 29, 32 which share high expression of CD11c and MHC class II but can be discriminated based on surface expression of CD26, CD64, CD24, CD207 (Langerin), CD103, XCR1, CD172a, and CD11b and by intracellular expression of the lineagedefining transcription factors IRF4 and IRF8 (see Fig 3 for detailed gating process). 22 The function of skin DCs has mainly been studied after painting irritating haptens to the skin or injection of antigens subcutaneously or intradermally. Exposure of ear skin to epicutaneous HDM induced a rapid increase in the number of DCs in SCLNs. As early as 1 day after allergen application, we observed an increase in the number of CD11b 1 cDC2s and CD11b 2 CD24 2 DN cDC2s in SCLNs (Fig 4, A) . The number of DN cDC2s peaked at day 2 after epicutaneous HDM and returned to baseline by day 4, whereas the number of CD11b 1 cDC2s kept increasing until day 4 after epicutaneous HDM application. CD24 1 cDC1s and LCs were recruited to the SCLNs only 2 days after epicutaneous HDM application. We did not find any increase in the number of CD11c 1 MHC class II 1 monocyte-derived cells (MCs) in the SCLNs (Fig 4, A) .
We next went on to identify the specific subsets of skin DCs, which were able to transport epicutaneously applied HDM to SCLNs. For this, ears were exposed to fluorescently labeled (Alexa Fluor 647) HDM. Four hours after application, fluorescent HDM could be detected in CD11c lo cells of the skin (Fig 4, B) . Application of fluorescent HDM did not induce any changes in numbers of skin macrophage and DC subsets at this time point compared with status after PBS application (Fig 4, C) . The fluorescent allergen was contained mostly in skin macrophages, MCs, LCs, and CD11b 1 cDC2s (Fig 4, D) . Almost no DN cDC2s and cDC1s were found to carry HDM in the skin (Fig 4, D) . When SCLNs were analyzed 48 hours after epicutaneous application, fluorescent (Fig 2, B) and HDM was detected mostly in very few CD11c hi cells (Fig 4,  E) . Contrary to the skin, epicutaneous HDM application induced a significant increase in numbers of all DC subsets analyzed compared with those in mice exposed to PBS (Fig 4, F) . In SCLNs the fluorescent HDM was mostly contained in cDC2s ( CD11b  1 and DN subset; Fig 4, G) . Strikingly, very few cDC1s, MCs, and LCs were found to carry HDM in SCLNs (Fig 4, G) .
FIG 2. Sensitization through the skin occurs only in the skin-draining LNs, and this is Der p 1 specific. A, Proliferation (CFSE dilution) and activation (CD44 expression) of 1-DER T cells in draining (SCLN) and nondraining LNs 4 days after epicutaneous HDM application. B and C, Percentage of cells in division
Epicutaneous sensitization to HDM is induced by IRF4-dependent cDC2s
Because several skin-derived DC subsets can capture allergen applied on the skin and transport it to the draining SCLNs, we next wanted to know which subset would be responsible for T H 2 sensitization to epicutaneous HDM. To address the contribution of MCs and LCs in this process, we made use of Flt3L-deficient (Flt3l 2/2 ) mice that still have LCs and MCs but in which all subsets of cDCs are lacking (Fig 5, A) . As expected, WT mice exposed epicutaneously to HDM and challenged intranasally with HDM had BAL lymphocytosis and eosinophilia (Fig 5, B) . These mice also showed strong IL-5 and IL-13 production by MLN cells after ex vivo restimulation with HDM compared with that in mice sensitized epicutaneously with PBS (Fig 5, C) . BAL eosinophilia was reduced by 50%, and T H 2 cytokine production was almost completely abolished in Flt3l 2/2 mice sensitized and challenged with HDM compared with control WT mice (Fig 5, B and C) , suggesting that cDCs are involved in T H 2 sensitization to epicutaneously applied HDM. However, LCs and MCs were sufficient to induce some degree of BAL eosinophilia.
To test the contribution of LCs and CD103 1 cDC1s, we made use of Langerin-DTR (Lang-DTR) mice lacking all Langerin 
cells (LCs and one subset of [CD103
1
] cDC1s) after diphtheria toxin injection (Fig 5, D) . To study the contribution of cDC2s, we made use of Cd11cCre-Irf4 fl/fl mice, which lack both subsets of cDC2s in the skin-draining LNs because of a migration defect of these cells (Fig 5, G) . When Lang-DTR mice injected with diphtheria toxin were subjected to the epicutaneous sensitization protocol when both LCs and CD103 1 cDC1s were absent, they showed similar degrees of airway eosinophilia than their WT counterparts (Fig 5, E and F) . Surprisingly, T H 2 cytokine production by MLN cells was strongly increased compared with that of WT littermates. Similar results were obtained if HDM was applied epicutaneously at a time when only LCs were absent (see Fig E2 in this article' s Online Repository at www.jacionline.org), suggesting that LCs, CD103 1 cDC1s, or both might play a role in inducing T-cell tolerance to epicutaneously applied allergen. When CD11c-Cre Tg Irf4 fl/fl mice were exposed to the same protocol, they did not have features of allergic airway inflammation compared with their littermate controls (Fig 5, H and I) . Altogether, these results suggest that mainly cDC2s, but not LCs or Langerin 1 CD103 1 cDC1s, are necessary to induce T H 2 sensitization to epicutaneously applied HDM.
IRF4-dependent skin-derived cDC2s are sufficient to induce allergic airway inflammation to HDM
We next wanted to know which subsets of skin DCs were sufficient to induce T H 2 sensitization to HDM. We first investigated which DC subsets would be able to stimulate the proliferation of CD4 1 1-DER naive T cells ex vivo. For this, different subsets of DCs (CD11b 1 cDC2s, DN cDC2s, CD103 1 cDC1s, and LCs) were sorted from SCLNs 36 hours after epicutaneous application of HDM or control PBS (Fig 6, A) and were cocultured for 3 days with CFSE-labeled, HDM-specific naive T cells. (Fig 4, B) and number of total skin macrophages (MFs) and DC subsets (Fig 4, C) 4 hours after epicutaneous PBS (white bars) and HDM (gray bars) application. D, Number of HDM-AF647 1 cells in the skin 4 hours after epicutaneous application of HDM-AF647. E and F, Uptake of fluorescent HDM by CD45 1 SCLN cells (Fig 4, E) and number of total DC subsets (Fig 4, F) in the SCLNs 48 hours after epicutaneous application of PBS or HDM-AF647. G, Number of HDM-AF647 1 cells in the SCLNs 2 days after epicutaneous application of PBS or HDM-AF647. Data are representative of at least 2 independent experiments and shown as means 6 SEs (n 5 6). *P < .05.
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As shown in Fig 6, B , only HDM-exposed CD11b 1 cDC2s and DN cDC2s induced 1-DER T-cell proliferation, whereas CD103 1 cDC1s and LCs did not (Fig 6, B) . However, the degree of proliferation induced by cDC2s was very low compared with that induced by the positive control, when exogenous HDM was added to the coculture (Fig 6, B) .
Because cDC2s were the only subsets able to stimulate naive T cells to proliferate, we wanted to know whether they would be able to induce T H 2 sensitization when adoptively transferred into naive mice. Different DC subsets were sorted from SCLNs of mice exposed epicutaneously to HDM or control PBS and were injected intradermally in naive C57Bl/6 mice on day 0. On days 7 to 11, mice were challenged intranasally with HDM. Only mice injected with HDM-exposed CD11b 1 cDC2s or HDMexposed DN cDC2s had features of allergic airway inflammation, as evidenced by the presence of BAL eosinophilia (Fig 6, C) and production of the T H 2 cytokines IL-5 and IL-13 by MLN cells restimulated with HDM ex vivo (Fig 6, D) . Mice injected with CD103 1 cDC1s or LCs did not mount T H 2 immunity to HDM. Together, these data show that IRF4-dependent CD11b 1 cDC2s and DN cDC2s are necessary and sufficient to induce type 2 immunity to epicutaneously applied HDM allergen.
DISCUSSION
The first barrier to protect against sensitization to allergens is made up of the epithelial layer, a physical, chemical, and immunologic barrier found in the skin and mucosa covering the gastrointestinal, genitourinary, and respiratory tracts. 45 Allergic inflammatory diseases are accompanied by increased permeability of various epithelia, including the skin and respiratory epithelium, which is caused, for example, by disruption of tight junction function or genetic or metabolic defects in filaggrin or hornerin. 11, 46, 47 As a consequence of subtle defects in epithelial barrier function, it is thought that underlying structural and immune cells become more susceptible to environmental triggers, such as HDM, pollutants, and viruses, all of which contain pathogen-associated molecular patterns. 48 Various epithelial cells, including skin keratinocytes, express Toll-like receptors and protease-activated receptors to interact with allergens and other environmental factors, leading to production of cytokines that promote T H 2 immunity by activating DCs and other innate immune cells. 2, 49 It has long been established that eczema constitutes a risk factor for development of sensitization to aeroallergens and (severe) asthma later in life. 5, 50, 51 Also, many children with signs of altered and defective epithelial barrier function (measured by TEWL) are at increased risk of aeroallergen sensitization. 52 Although this has led to the assumption that the skin might be a portal of entry for allergens, the actual route and mechanism of sensitization to aeroallergens has not been studied in great detail but has been modeled in mouse skin, where epicutaneous application of model and real-life allergens leads to T H 2 immunity. 37, 40, 44, 53, 54 One caveat to many of the previously published models of skin sensitization is the fact that the skin was altered by shaving or tape stripping or by use of irritants, such as dimethyl sulfoxide or depilatory creams. 37, 42, 43 The ensuing epithelial leakiness, damage, and inflammation caused by these actions might act as an adjuvant, overestimating the real potential of allergens to cause sensitization when applied on an intact skin. [55] [56] [57] Therefore we have developed a model of epicutaneous application of allergens on the intact ears of mice and compared it with a model in which allergens were applied on shaved skin. We essentially found that sensitization did not require shaving of the mice or application of an occlusive dressing tape, but instead, it could be induced by the simple painting of HDM extracts on the ear skin of an anesthetized mouse. However, both shaving on the flank skin and use of an occlusive dressing on the ears enhanced most features of allergic inflammation that were induced. Therefore it is very likely that these methods induce some degree of keratinocyte damage 58 associated with a stronger innate response. This damage was reflected by a mild increase in TEWL that was not near the degree of TEWL induced by using the tape-stripping procedure.
In this model of epicutaneous sensitization under an overnight occlusive dressing, penetration of the skin could occur as a result of the proteolytic activity of some allergens, such as Der p 1 or Der p 9, which are capable of cleaving epithelial tight junction proteins and in this way gaining access to immune cells. 53, [59] [60] [61] [62] Although this is an elegant hypothesis, the requirement for the proteolytic activity of allergens in the process of sensitization is still debated. As such, some studies show that induction of T H 2 responses through the skin by the cysteine protease papain is mediated by its enzymatic activity, 53, 54, 60, 63 whereas others have shown that this is not the case. 60 The reason for such a discrepancy might come from the differences in application of the allergen at times of first allergen application, with one study using hair removal and the other using tape stripping, raising the issue as to whether proteolytically active allergens are responsible for T H 2 sensitization after application on intact skin.
We have carefully compared the development of T H 2 immunity between mice undergoing application of crude or heat-inactivated HDM extracts on intact ear skin and found that both types of extracts induced sensitization to a similar extent. Our data show that proteases, such as Der p 1 and Der p 9, which are present in our allergen extracts, are not required to induce proper sensitization, leading to development of allergic airway inflammation. This was also confirmed by using an irreversible cysteine proteinase inhibitor, which was previously used to block the activity of Der p 1 and the cysteine proteinase papain in a model of epicutaneous sensitization. 63 Which allergens are responsible for HDM sensitization through the skin is currently unknown. Recent studies have shown the possibility of inducing T H 2 immunity to HDM allergens, such as Der p 1 and Der p 2, which are contained in mite fecal pellets, 5, 53, 59 but this was studied in the context of altered skin barrier function. Although many allergens are found in fecal pellets of HDMs, it was also shown previously that sensitization through the skin in human subjects with atopic dermatitis leads to IgE reactivity to mite body allergens not contained in the fecal pellets. 5 Because the allergen used was whole HDM extract subsets. C and D, Differential cell counts in BAL fluid (Fig 6, C) and cytokine production of MLN cells (Fig 6, D) from mice injected intradermally with HDM 1 DC subsets. In Fig 6 , B, data are representative of at least 4 independent experiments. In Fig 6 , C and D, data from 2 independent experiments have been pooled and shown as means 6 SEs (n 5 4-12). *P < .05. e.c., Epicutaneous; i.d., intradermal, i.n., intranasal.
(including fecal pellets), it is possible that epicutaneous sensitization in mice also favors sensitization to mite body allergens, although a clear response to Der p 1 antigen was detected by using TCR transgenic 1-DER T cells. Underneath the skin barrier, DCs are lined up to scan for incoming allergens. The skin and skin-draining LNs contain 5 major DC subsets, 29, 32 the function of which has mainly been studied after painting of irritative haptens on the skin or injection of antigens subcutaneously or intradermally. Through extension of dendritic processes, DCs, especially LCs, can penetrate the epithelium until just below the stratum corneum without breaching the barrier function. 64 In this way LCs were shown to gain access to and capture antigens deposited on the skin. Therefore it was very surprising that fluorescently labeled HDM applied on the skin was not found in LCs or in the different dermal cDC subsets analyzed but rather in macrophages localized in the dermis. In our study a high dose of allergen was used, and it is possible that such a dose is able to reach cells in the dermis without the need for LCs. Another explanation might be that most LCs and dermal cDCs that would have taken up the allergen emigrated from the skin to reach the draining SCLNs. However, 24 hours after HDM epicutaneous application, the major cell types that contained allergens in the ipsilateral SCLNs were 2 subsets of cDC2s (CD11b 1 and DN cDC2s) and almost no allergen-bearing LCs were present, which is consistent with a previous report showing that skin-derived cDCs migrate faster to the LNs than LCs. 38, 65, 66 Whether cDC2s have captured allergen in the skin or whether the allergen would have been transferred by other DC subsets, macrophages, or both remains to be addressed, but in any case the CCR7 chemokine receptor was involved, implying a direct transport by DCs. Also, after skin administration of proteolytic HDM allergen extract, divisions were only seen in the ipsilateral skindraining LNs, suggesting that there was no leakiness of antigen applied to the skin to the systemic circulation, in which case the spleen would show T-cell divisions. This is in clear contrast to the lung, where the same dose of HDM extract does reach the systemic circulation and induce primary divisions in HDM-reactive splenocytes (data not shown). In the skin the migration of DCs to the draining LNs is controlled by CCR7 responsiveness 67 and by the transcription factor IRF4, which is mainly expressed by cDC2s. 68 Not surprisingly, the amount of cDC2s was strongly reduced in the SCLNs of Cd11cCre Irf4 fl/fl mice that received HDM allergen. The underrepresentation of cDC1s in the SCLNs 24 to 48 hours after epicutaneous allergen exposure is best explained by the fact that these cells have a poor chemotactic response to CCR7 ligands. 66 A consequence of DC migration to the draining LNs is the activation of antigen-specific T cells. Our data clearly show that both cDC2 subsets sorted from SCLNs 24 hours after HDM exposure were the only DCs capable of inducing Der p 1-specific T-cell proliferation to some extent (Fig 5) . The few LCs or cDC1s present in the SCLNs at this time point were unable to do so. It was surprising to us that LCs did not induce HDM-specific T-cell proliferation because in a model in which the protein ovalbumin was applied on the skin of mice, T-cell proliferation was blunted when LCs were depleted. 69 A major difference with our model is that the authors shaved the skin of mice before antigen application, which might have facilitated the uptake and migration of LCs to the draining LNs through induction of the cytokine thymic stromal lymphopoietin. As a consequence, Nakajima et al 69 30, [70] [71] [72] [73] In our study we have not fully excluded the involvement of Langerin 2 cDC1s in T H 2 skin sensitization to HDM because only Langerin 1 cDC1s were targeted in Lang-DTR mice. However, Batf3-dependent cDC1s have been reported to be a major source of IL-12, favoring T H 1 immune responses, and in this way they might prevent T H 2 immunity from developing. 74, 75 We have also previously demonstrated that Langerin 1 CD103 1 cDC1s can drive the generation of regulatory T cells through the production of retinoic acid. 28 Therefore it is possible that increased production of T H 2 cytokines observed in Langerin 1 DC-depleted animals might be attributed to a lack of these regulatory cells (Fig 4) .
Recently, we described that CD11b 1 cDC2s are the most important subset inducing sensitization after application of HDM extracts in the lungs of adult and neonatal mice, whereas CD103 1 cDC1s were not necessary. 17, 76 When our epicutaneous HDM sensitization model was performed in Flt3l 2/2 mice lacking cDCs, there was a strong reduction in the degree of BAL eosinophilia and T H 2 cytokine production by SCLN cells, pointing to the fact that cDCs are crucial in the induction of T H 2 responses to HDM applied on skin. However, one difference with the lung is that the same 100 mg of HDM applied to the lung also caused sensitization in Flt3l 2/2 mice, whereas a low dose of antigen could not cause sensitization in Flt3l 2/2 mice. The explanation that we found in the lung experiments was that the dose of antigen stimulating the lung epithelium was decisive in causing MCs to also present antigen in the mediastinal nodes. 17 Therefore in the current epicutaneous model we believe that there is much less antigen penetration into the skin barrier with 100 mg of HDM extract, a finding supported by the idea that very few HDM-positive cells could be traced in the SCLNs. Experiments performed in CD11cCre Irf4 fl/fl mice identified IRF4-dependent cDC2s as the main inducers of skin sensitization to HDM. Our data are in agreement with those of other studies showing that IRF4-expressing DCs could control T H 2 responses to allergens in the lung and to papain injected into the skin 19, 34, 36 because IRF4 controls cDC2 migration to SCLNs, 68 the permeability and fibrosis of afferent lymphatics, 77 and the expression of costimulatory molecules and MHC class II on this subset of DCs. 78 Within the IRF4-dependent skin cDC2s comprising CD11b 1 and DN cDC2s, the pro-T H 2 potential was recently attributed solely to the Klf4-dependent DN subset. 36 However, when we sorted both cDC2 subsets from SCLNs of mice exposed epicutaneously to HDM and adoptively transferred them intradermally into naive recipients, we found that both subsets of cDC2s could promote T H 2 sensitization to HDM. Although the idea of a specialized subset of Klf4 1 cDC2s restricted to the induction of T H 2 responses is appealing, our data suggest that the type of antigen encountered together with environmental cues might give some plasticity to Klf4 2 cDCs to also drive T H 2 responses. Within the population of IRF4-dependent DCs, there is also a subset of cells expressing the C-type lectin Mgl2, which was also shown to promote T H 2 responses to the model allergen papain. Recently, this subset was also shown to suppress humoral immune responses and formation of follicular helper T (T FH ) cells to epicutaneous HDM allergen. 79 Although this would suggest a tolerogenic role for Mgl2 1 cDC2s, it is also possible that induction of T FH cells and effector or resident memory T H 2 cells are mutually exclusive fates of naive allergen-reactive T cells and that suppression of T FH cell formation inevitably leads to increased T H 2 immunity. Such a model was recently proposed by different groups studying HDM-reactive T-cell differentiation in B cell2deficient and Bcl6-deficient mice that also lack T FH cell formation. 80, 81 The fact that murine DN cDC2s can induce T H 2 responses to allergens in the skin brings up the question of translation of these findings in human subjects because no counterparts for this murine subset have been identified in human skin. 22, 29 In our hands, however, IRF4-dependent CD11b 1 cDC2s can also induce T H 2 sensitization to HDM through the skin. In human subjects CD1c
1 DCs are the counterpart of this mouse population 29 and have been shown to activate T H 2 responses to inhaled allergens ex vivo. 82 Whether this human subset is involved in the induction of T H 2 responses in the skin remains to be addressed.
In conclusion, we have shown that sensitization to relevant inhaled allergens, such as HDM, can occur through intact skin and does not require the protease activity of the allergen. This type of epicutaneous sensitization is driven by 2 variants of IRF4-dependent cDC2 subsets but not by LCs. Future studies will have to reveal how genetic or inflammation-induced alterations in skin barrier proteins (eg, the well-known filaggrin polymorphism) or cytokines (eg, thymic stromal lymphopoietin [TSLP] gene polymorphism) in patients at risk for asthma could interfere with this basic mechanism of DC-driven type 2 immunity.
Key messages
d Epicutaneous sensitization to mite allergen can occur through intact skin yet is facilitated by occlusive tape.
d Epicutaneous sensitization to mite allergen does not require the enzymatic activity of the allergen.
d Epicutaneous sensitization to mite allergen is driven by 2 variants of IRF4-dependent DCs but not LCs.
